Wt Asset Management LTD Zai Lab LTD Transaction History

Wt Asset Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 26, 2022	SELL	$54.9 - $105.21 $4.51 Million - $8.65 Million	-82,180 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$105.0 - $178.37 $9.45 Million - $16.1 Million	-90,020 Reduced 52.28%	82,180 $8.66 Million
Q2 2021 Jul 23, 2021	BUY	$125.11 - $180.0 $18.1 Million - $26 Million	144,300 Added 517.2%	172,200 $30.5 Million
Q1 2021 Apr 23, 2021	BUY	$126.27 - $191.71 $3.52 Million - $5.35 Million	27,900 New	27,900 $3.72 Million

117

40.9M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.43B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Wt Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Wt Asset Management LTD with notifications on news.